Nevada research on women's health is getting an $8 million boost thanks to a settlement with pharmaceutical companies.
The University of Nevada School of Medicine is getting $3.8 million over 5 years, and Las Vegas' University Medical Center is getting another $3.8 million.
The state had sued drugmakers Wyeth, Pfizer and Pharmacia & Upjohn, arguing that they misled consumers about the risks of postmenopausal hormone therapy products. Nevada settled last year.
Researchers at the medical school already have plans for the funding. The pharmacology department purchased a super-resolution microscope that's the first of its kind in Nevada and will aid research on breast cancer and premature birth.
The money is also expected to support a Women's Heart Center that addresses the needs of women at risk for heart disease.